文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

无标准可调节心血管风险因素的 ST 段抬高型心肌梗死(STEMI)患者——他们有多常见,其结局如何?

ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?

机构信息

Cardiothoracic and Vascular Health Kolling Institute and Department of Cardiology Royal North Shore Hospital Northern Sydney Local Health District St Leonards Australia.

Charles Perkins Centre University of Sydney Australia.

出版信息

J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1.


DOI:10.1161/JAHA.119.013296
PMID:31672080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6898813/
Abstract

Background Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF-less individuals is not uncommon. This study uses 2 sequential large, multicenter registries to examine the proportion and outcomes of SMuRF-less ST-segment-elevation myocardial infarction (STEMI) patients. Methods and Results We identified 3081 STEMI patients without a prior history of cardiovascular disease in the Australian GRACE (Global Registry of Acute Coronary Events) and CONCORDANCE (Cooperative National Registry of Acute Coronary Syndrome Care) registries, encompassing 42 hospitals, between 1999 and 2017. We examined the proportion that were SMuRF-less as well as outcomes. The primary outcome was in-hospital mortality, and the secondary outcome was major adverse cardiovascular events (death, myocardial infarction, or heart failure, during the index admission). Multivariate regression models were used to identify predictors of major adverse cardiovascular events. Of STEMI patients without a prior history of cardiovascular disease 19% also had no history of SMuRFs. This proportion increased from 14% to 23% during the study period (=0.0067). SMuRF-less individuals had a higher in-hospital mortality rate than individuals with 1 or more SMuRFs. There were no clinically significant differences in major adverse cardiovascular events at 6 months between the 2 groups. Conclusions A substantial and increasing proportion of STEMI presentations occur independently of SMuRFs. Discovery of new markers and mechanisms of disease beyond standard risk factors may facilitate novel preventative strategies. Studies to assess longer-term outcomes of SMuRF-less STEMI patients are warranted.

摘要

背景 针对标准可调节心血管风险因素(SMuRFs:高血压、糖尿病、高胆固醇血症、吸烟)的计划对于在社区层面解决冠心病至关重要。然而,SMuRF 缺乏的个体发生心肌梗死并不罕见。本研究使用 2 个连续的大型多中心登记处,检查 SMuRF 缺乏的 ST 段抬高型心肌梗死(STEMI)患者的比例和结局。

方法和结果 我们在澳大利亚 GRACE(全球急性冠状动脉事件登记处)和 CONCORDANCE(急性冠状动脉综合征协同国家登记处)登记处中确定了 3081 例无心血管疾病既往史的 STEMI 患者,该登记处包括 1999 年至 2017 年间的 42 家医院。我们检查了 SMuRF 缺乏的比例以及结局。主要结局是院内死亡率,次要结局是主要不良心血管事件(索引入院期间死亡、心肌梗死或心力衰竭)。使用多变量回归模型确定主要不良心血管事件的预测因素。在无心血管疾病既往史的 STEMI 患者中,有 19%也没有 SMuRFs 既往史。在此期间,这一比例从 14%增加到 23%(=0.0067)。与有 1 种或多种 SMuRFs 的个体相比,SMuRF 缺乏的个体院内死亡率更高。两组在 6 个月时主要不良心血管事件无临床显著差异。

结论 大量且不断增加的 STEMI 发作独立于 SMuRFs 发生。除标准危险因素外,发现新的疾病标志物和机制可能有助于制定新的预防策略。需要评估 SMuRF 缺乏的 STEMI 患者的长期结局的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5688/6898813/fb7e185d14a1/JAH3-8-e013296-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5688/6898813/f7b4b65f3fb1/JAH3-8-e013296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5688/6898813/fb7e185d14a1/JAH3-8-e013296-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5688/6898813/f7b4b65f3fb1/JAH3-8-e013296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5688/6898813/fb7e185d14a1/JAH3-8-e013296-g002.jpg

相似文献

[1]
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?

J Am Heart Assoc. 2019-11-1

[2]
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.

Lancet. 2021-3-20

[3]
Outcomes of ST Segment Elevation Myocardial Infarction without Standard Modifiable Cardiovascular Risk Factors - Newer Insights from a Prospective Registry in India.

Glob Heart. 2023

[4]
Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.

J Am Heart Assoc. 2022-8-2

[5]
Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable Risk Factors.

Am J Cardiol. 2023-9-1

[6]
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.

Eur J Prev Cardiol. 2017-7-13

[7]
Infarct severity and outcomes in ST-elevation myocardial infarction patients without standard modifiable risk factors - A multicenter cardiac magnetic resonance study.

Eur J Intern Med. 2024-1

[8]
Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry.

BMC Med. 2022-7-6

[9]
Mortality of patients presented with acute ST-segment elevation myocardial infarction according to the status of standard modifiable cardiovascular risk factors.

Am J Med Sci. 2024-5

[10]
Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: A report from multicenter percutaneous coronary intervention registry.

J Cardiol. 2023-6

引用本文的文献

[1]
Added prognostic value of fat attenuation index and CT-derived fractional flow reserve over plaque burden in suspected CAD patients without standard modifiable risk factors.

Afr Health Sci. 2024-9

[2]
Strategies for assessing and preventing cardiovascular disease risk in inflammatory bowel disease patients: A meta-analysis and meta-regression and bibliometric review.

PLoS One. 2025-7-28

[3]
Poor Mental Health Status as a Risk Factor and Prognosticator in SMuRF-Less Acute Myocardial Infarction.

J Clin Med. 2025-4-11

[4]
In-Hospital Outcomes in Patients With Acute Myocardial Infarction and No Standard Modifiable Cardiovascular Risk Factors Across Varying Body Mass Index: Findings From the CCC-ACS Project.

J Am Heart Assoc. 2025-4

[5]
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.

Nutrients. 2025-3-6

[6]
Efficacy of sacubitril/valsartan on improving clinical symptoms in patients with acute myocardial infarction complicated with heart failure: a retrospective study.

PeerJ. 2025-2-11

[7]
Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.

Vasc Health Risk Manag. 2025-2-5

[8]
Plasma proteomics improves prediction of coronary plaque progression.

Eur Heart J Cardiovasc Imaging. 2025-3-3

[9]
Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors.

Am Heart J. 2025-3

[10]
Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.

Clin Res Cardiol. 2025-6

本文引用的文献

[1]
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.

J Am Coll Cardiol. 2018-10-16

[2]
Utilizing state-of-the-art "omics" technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease.

Microcirculation. 2019-2

[3]
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.

J Am Coll Cardiol. 2017-12-19

[4]
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.

J Am Coll Cardiol. 2017-11-12

[5]
Socioeconomic Equity in the Receipt of In-Hospital Care and Outcomes in Australian Acute Coronary Syndrome Patients: The CONCORDANCE Registry.

Heart Lung Circ. 2018-12

[6]
Fine particulate matter and cardiovascular disease: Comparison of assessment methods for long-term exposure.

Environ Res. 2017-11

[7]
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.

Eur J Prev Cardiol. 2017-7-13

[8]
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

J Am Coll Cardiol. 2017-7-4

[9]
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 2016-10-8

[10]
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Eur Heart J. 2016-8-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索